The association of postoperative radiotherapy with survival in resected N2 non-small cell lung cancer.

ABSTRACT:

Background

The current staging system for completely resected pathologic N2 non-small cell lung cancer (NSCLC) treated with chemotherapy is not suitable for distinguishing those patients most likely to benefit from postoperative radiotherapy (PORT). This study aimed to construct a survival prediction model that will enable individualized prediction of the net survival benefit of PORT in patients with completely resected N2 NSCLC treated with chemotherapy.

Methods

A total of 3,094 cases from between 2002 and 2014 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Patient characteristics were included as covariates, and their association with overall survival (OS) with and without PORT was assessed. Data from 602 patients from China were inclu

SUBMITTER: Zeng Y 

PROVIDER: S-EPMC9922593 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature